Pure Global
Back to Glossary
🏛️

COFEPRIS

Comisión Federal para la Protección contra Riesgos Sanitarios

Regulatory Authorities
🇲🇽 Mexico
Updated 2025-12-23
Quick Definition

COFEPRIS (Comisión Federal para la Protección contra Riesgos Sanitarios) is la Comisión Federal para la Protección contra Riesgos Sanitarios de México, responsable de regular dispositivos médicos, medicamentos y seguridad alimentaria en México.

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Complete Guide to COFEPRIS

COFEPRIS (Comisión Federal para la Protección contra Riesgos Sanitarios) is Mexico's health regulatory agency, equivalent to the FDA in the United States. It operates under the Ministry of Health (Secretaría de Salud) and is responsible for protecting the population from health risks.

COFEPRIS responsibilities:
- Medical device registration and surveillance
- Pharmaceutical drug approval
- Food and beverage safety
- Tobacco and alcohol control
- Chemical and environmental health risks
- Advertising of health products

Medical device classification in Mexico:
- Class I - Low risk (notification)
- Class II - Moderate risk (registration)
- Class III - High risk (registration with clinical data)

Registration requirements:
- Foreign manufacturers must appoint a Mexican Registration Holder (MRH)
- Certificate of Free Sale from country of origin
- Good Manufacturing Practice (GMP) certificate
- Technical file in Spanish
- Mexican labeling requirements

Key regulations:
- NOM-241-SSA1-2012 - GMP for medical devices
- NOM-137-SSA1-2008 - Labeling requirements
- Various specific NOMs for device categories

Registration timeline: Typically 4-8 months depending on device class.

Mexico is the second-largest medical device market in Latin America and a key entry point for companies targeting the LATAM region.

Related Terms

MRHNOMANVISAHealth Canada

More Regulatory Authorities

View all

Need Help with Mexico Registration?

Pure Global provides regulatory consulting and AI-powered tools to help medical device companies navigate Mexico market access.